Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2017

Aug 4, 2017

32337_dirs_2017-08-04_292e755d-58ab-42f4-a343-c36b1bcee7fd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2017-08-01

Reporting Person: Harms Thomas (SVP, China & APAC)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Appreciation Right $21.57 2018-02-28 Common Stock (1000) Direct
Stock Appreciation Right $6.82 2019-02-27 Common Stock (6000) Direct
Stock Appreciation Right $6.82 2019-02-27 Common Stock (15000) Direct
Stock Appreciation Right $22.94 2020-05-07 Common Stock (5032) Direct
Stock Appreciation Right $53.29 2021-05-18 Common Stock (4167) Direct
Stock Appreciation Right $67.70 2022-03-01 Common Stock (3711) Direct
Stock Appreciation Right $44.79 2022-05-31 Common Stock (11803) Direct
Stock Appreciation Right $79.58 2023-12-19 Common Stock (5448) Direct
Stock Appreciation Right $59.98 2024-04-30 Common Stock (6639) Direct
Stock Appreciation Right $30.44 2025-03-02 Common Stock (9176) Direct
Stock Appreciation Right $62.51 2026-05-09 Common Stock (3023) Direct
Stock Appreciation Right $57.19 2027-02-27 Common Stock (3177) Direct

Footnotes

F1: On February 28, 2008 the reporting person was granted 6,000 Stock Appreciation Right ("SARs"). These SARs were fully vested as of February 28, 2011.

F2: On February 27, 2009 the reporting person was granted 6,000 SARs. These SARs were fully vested as of February 27, 2012.

F3: On February 27, 2009 the reporting person was granted 15,000 SARs. These SARs were fully vested as of February 27, 2014.

F4: On May 7, 2010 the reporting person was granted 5,032 SARs. These SARs were fully vested as of May 7, 2013.

F5: On May 18, 2011, the reporting person was granted 4,167 SARs. These SARs were fully vested as of May 18, 2014.

F6: On March 1, 2012, the reporting person was granted 3,711 SARs. These SARs were fully vested as of March 1, 2015.

F7: On May 31, 2012, the reporting person was granted 11,803 SARs. These SARs were fully vested as of May 31, 2015.

F8: On December 19, 2013, the reporting person was granted 5,448 SARs. These SARs were fully vested as of December 19, 2016.

F9: On April 30, 2014, the reporting person was granted 6,639 SARs. These SARs were fully vested as of April 30, 2017.

F10: On March 2, 2015, the reporting person was granted 9,176 SARs. Forty percent (40%) of these SARs were vested as of March 2, 2017, and the remaining sixty percent (60%) will vest on March 2, 2018.

F11: On May 9, 2016, the reporting person was granted 3,023 SARs. Twenty percent (20%) of these SARs were vested as of May 9, 2017, twenty percent (20%) will vest on May 9, 2018, and the remaining sixty percent (60%) will vest on May 2, 2019.

F12: On February 27, 2017, the reporting person was granted 3,177 SARs. Twenty percent (20%) of these SARs will vest on each of February 27, 2018 and February 27, 2019, and the remaining sixty percent (60%) will vest on February 27, 2020.